Ganitumab disappoints in pancreatic cancer: Amgen halts Phase III Study
In a press release on August 8, 2012, Amgen announced that the company was halting a late-stage trial of its monoclonal antibody IGF-1 receptor antagonist ganitumab (AMG-479).
In a press release on August 8, 2012, Amgen announced that the company was halting a late-stage trial of its monoclonal antibody IGF-1 receptor antagonist ganitumab (AMG-479).
by Zara Qadir – Every year, the EAHP holds a best poster competition to encourage hospital pharmacists from all over Europe and beyond, to share best practices and… read more.
CHICAGO – A study evaluating off-label prescribing of medications in a primary care network in Canada suggests the practice is common, although it varies by medication, patient and… read more.
by Zara Qadir – The role of consultant pharmacist was introduced seven years ago by the National Health Service (NHS) in the UK, with the intention of improving… read more.
by Zara Qadir reporting on the presentation by Professor Petra Thürmann (pictured) from the Philipp Klee-Institute of Clinical Pharmacology at the HELIOS Klinikum Wuppertal in Germany.
by Bruce Sylvester – taken from The Journal of the American Medical Association (JAMA) Researchers in a large, retrospective study report that daily use of low-dose aspirin is… read more.
Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) doubled at academic medical centers in the U.S. between 2003 and 2008, according to a report published in the August issue… read more.
by Thomas R. Collins – Liver transplants involving selected organs from elderly patients performed just as well as livers from usual donors,
by Thomas R. Collins – A living donor liver transplant can be a safe and effective first-line treatment for very young children with biliary atresia,
Dr Irene Scalera, Fellow at the Liver Unit at Queen Elizabeth Hospital, Birmingham, describes the ever-changing donor landscape and attempts to improve liver donor shortage.
World Health Matters (U.S.A.) – by Gary Finnegan – The United States is paying far more for health services than 12 comparable industrialised nations but the quality of… read more.
by Dr Sunil Upadhyay – Age is the number one risk factor for the development of breast cancer. Not only the incidence but also the mortality from breast… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.